← back to search

Yi Qin

First Affiliated Hospital of Hunan University of Traditional Chinese Medicine · CN
🔎 Find collaborators in Oncology · Epidemiology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Oncology · Epidemiology
Research interest
Research interests include Neuroendocrine Tumor Research Advances, Pancreatic and Hepatic Oncology Research, Ferroptosis and cancer prognosis, and Lung Cancer Research Studies.
h-index
51
citations
9,055
works
372
NIH funding
primary concept
email

Recent publications

Liquid-Liquid Phase Separation in Major Hallmarks of Cancer.
2026cited by 1position: contributordoi
Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor-Stroma Ratio and Promote Cancer Progression.
2025cited by 3position: contributordoi
ACSS2/AATF Drives Soluble FasL-Mediated CD8<sup>+</sup> T Cell Apoptosis in Pancreatic Neuroendocrine Tumors.
2025cited by 2position: contributordoi
Table S1 from Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor–Stroma Ratio and Promote Cancer Progression
2025cited by 1position: contributordoi
Table S4 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
2025cited by 0position: contributordoi
Figure S6 from Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor–Stroma Ratio and Promote Cancer Progression
2025cited by 0position: contributordoi
Table S3 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
2025cited by 0position: contributordoi
Figure S1 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
2025cited by 0position: contributordoi
Table S3 from ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells
2025cited by 0position: contributordoi
Figure S4 from Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor–Stroma Ratio and Promote Cancer Progression
2025cited by 0position: contributordoi
Table S2 from ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells
2025cited by 0position: contributordoi
Figure S2 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
2025cited by 0position: contributordoi
Data from Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor–Stroma Ratio and Promote Cancer Progression
2025cited by 0position: contributordoi
Figure S5 from Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor–Stroma Ratio and Promote Cancer Progression
2025cited by 0position: contributordoi
FigureS1-S11 from ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells
2025cited by 0position: contributordoi
Figure S7 from Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor–Stroma Ratio and Promote Cancer Progression
2025cited by 0position: contributordoi
Table S5 from Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor–Stroma Ratio and Promote Cancer Progression
2025cited by 0position: contributordoi
Table S1 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
2025cited by 0position: contributordoi
Figure S3 from Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor–Stroma Ratio and Promote Cancer Progression
2025cited by 0position: contributordoi
Data from ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells
2025cited by 0position: contributordoi
Table S2 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
2025cited by 0position: contributordoi
Figure S1 from Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor–Stroma Ratio and Promote Cancer Progression
2025cited by 0position: contributordoi
Table S4 from Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor–Stroma Ratio and Promote Cancer Progression
2025cited by 0position: contributordoi
Figure S8 from Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor–Stroma Ratio and Promote Cancer Progression
2025cited by 0position: contributordoi
Table S1 from ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells
2025cited by 0position: contributordoi
Figure S2 from Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor–Stroma Ratio and Promote Cancer Progression
2025cited by 0position: contributordoi
Table S3 from Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor–Stroma Ratio and Promote Cancer Progression
2025cited by 0position: contributordoi
Data from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
2025cited by 0position: contributordoi
Table S2 from Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor–Stroma Ratio and Promote Cancer Progression
2025cited by 0position: contributordoi
Cancer immunometabolism: advent, challenges, and perspective
Molecular Cancer 2024cited by 43position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 101 papers (2019–2026)Xianjun Yu · Ningbo University77 papers (2013–2025) · 65 papers (2021–2025)Xiaowu Xu · Springer Nature64 papers (2022–2025)Yue Zhang · Soochow University61 papers (2023–2025)Fei Wang · Shanghai Medical College of Fudan University61 papers (2023–2025)Wuhu Zhang · Fudan University61 papers (2023–2025)Xin Llou · Shanghai Medical College of Fudan University61 papers (2023–2025)Yan Wang · Shanghai Medical College of Fudan University61 papers (2023–2025)Zeng Ye · Fudan University Shanghai Cancer Center61 papers (2023–2025)Junfeng Xu · Shanghai Medical College of Fudan University61 papers (2023–2025)Jie Chen · Shanghai Medical College of Fudan University61 papers (2023–2025)Guixiong Fan · Shanghai Medical College of Fudan University61 papers (2023–2025)Desheng Jing · 61 papers (2023–2025)Shunrong Ji · Shanghai Medical College of Fudan University46 papers (2023–2025)Heli Gao · 46 papers (2023–2025)Xuemin Chen · Guangxi Medical University46 papers (2023–2025)Qifeng Zhuo · Shanghai Medical College of Fudan University46 papers (2023–2025)Peng Zhang · Shihezi University34 papers (2023–2025)Lele Zhang · Beijing Proteome Research Center34 papers (2023–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Oncology · Epidemiology →